Programme

Thursday 30 March 2023

14:00–15:00
Introduction

14:00
O. Viklicky and G. Bohmig: Welcome words

14:15
P. F. Halloran (Edmonton): Personal view why I decided to study gene transcripts in transplantation

14:30
P. F. Halloran (Edmonton): A new archetypes in kidneys and hearts

15:15–17:05
Molecular assessment of kidney graft biopsies in a real life

Chairs: Agnieszka Perkowska-Ptasinska, Klemens Budde

15:15
G. Bohmig (Vienna): What do clinicians need?

15:35
H. Regele (Vienna): Where pathologists see indications for MMDx

15:50
G. Einecke (Hannover): Molecular assessment of ABMR

16:05
P. Hruba and O. Viklicky (Prague): How we implemented MMDx in the clinical routine

16:20
O. Viklicky (Prague): MMDx as rapid diagnostics of ABMR in patients at highest risk

16:35
M. Novotny (Prague): May MMDx save healthcare costs for unnecessary treatment?

16:50
M. Exner (Vienna): Hurdles with MMDx implementation: my experiences

17:05–17:30
Coffee break

17:30–18:00
Molecular pathology in lung transplantation

Chairs: P. Halloran, M. Myślak

17:30
M. Mackova (Edmonton): Transcripts associated with chronic lung allograft dysfunction in transbronchial biopsies or airway mucosa

17:50
J. Havlin (Prague): Interesting cases from Prague

18:00–18:45
Round table discussion: MMDx in a routine praxis

A. Perkowska-Ptasinska, B. Sax, T. Reischig and all participants

Friday 31 March 2023

8:30–9:20
Molecular assessment of heart biopsies in a real life

Chairs: B. Sax, A. Zuckermann

8:30
A. Zuckermann (Vienna): Advantages of molecular diagnostics in heart transplantation

8:50
V. Melenovsky (Prague): How do I use MMDx in the decision-making process in heart transplantation?

9:10
K. Koubsky (Prague): Problematic pediatric case: heart transplantation

9:20–9:50
Coffee break

9:50–11:10
dd cf DNA in the clinic

Chairs: U. Maggiore, M. Arnol

9:50
K. Budde (Berlin): Charite experiences with dd cf DNA – implications for the clinic

10:10
K. Mayer (Vienna): dd-cf DNA Vienna experiences

10:30
K. Madill-Thomsen and P. Halloran (Edmonton): Correlation of dd-cf DNA and MMDX (Trifecta study)

10:50
D. Cucchiari (Barcelona): Use of ddcfDNA early after transplantation and prognostic consequences

11:15–12:00
Round Table: what is the future of dd cf DNA in organ transplantation?

Klemens Budde, Umberto Maggiore, Miha Arnol, and all participants

last update on 17 March 2023